Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
During the COVID-19 pandemic, the time spent at the home of patients has increased because of national quarantine policies and patients' fear of getting sick. For this reason, in this ongoing process, patients have been unable to go to work regularly due to their chronic diseases (being on administrative leave) and their fear of going out. These reasons have prevented being physically active. The aim of the study is to evaluate the physical activity level, quality of life, glucose control, anxiety, depression, fear of hypoglycemia and loneliness perceptions of patients with type 1 diabetes mellitus during the COVID-19 pandemic period and compared with healthy controls.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients with type 1 diabetes mellitus | Patients with Type 1 diabetes mellitus willing to participate in the study |
| |
| Healthy controls | Healthy controls without chronic disease willing to participate in the study |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Online Survey | Other | Online surveys will be applied to all participants |
|
| Measure | Description | Time Frame |
|---|---|---|
| Physical activity level | Physical activity level using International Physical Activity Questionnaire - Short Form (IPAQ-SF) will be evaluated. | Five minutes |
| General Quality of life | Quality of life using Short Form Health Survey (SF-36) will be evaluated. | Ten minutes |
| Measure | Description | Time Frame |
|---|---|---|
| Depression | Depression using Hospital Anxiety and Depression Scale will be evaluated. | Three minutes |
| Anxiety | Anxiety using Hospital Anxiety and Depression Scale will be evaluated. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Patients with type 1 diabetes mellitus and healthy controls between 18-65 years
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Zeliha ÇELİK, MSc | Gazi University | Study Chair |
| Meral BOŞNAK GÜÇLÜ, Prof | Gazi University | Study Director |
| Füsun BALOŞ TÖRÜNER, Prof | Gazi University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Zeliha ÇELİK | Ankara | Çankaya | 06490 | Turkey (Türkiye) |
Not provided
| ID | Term |
|---|---|
| D003922 | Diabetes Mellitus, Type 1 |
| D000086382 | COVID-19 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Three minutes |
| Self-reported hypoglycemia | It will be questioned how many times patients have had hypoglycemic attacks (<4 mmol/L and common symptoms) in the last 7 days. | Last seven day |
| Loneliness | Loneliness using UCLA Loneliness Scale Short Form (ULS-8) will be evaluated. | Three minutes |
| Hypoglisemia fear | Hypoglisemia fear using Hypoglisemia Fear Survey (HFS) will be evaluated. | Five minutes |
| Dyspnea | Dyspnea during daily life activites using Modified Medical Research Dyspnea Scale will be evaluated. | Two minutes |
| D004700 | Endocrine System Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
| D014777 | Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |